-
Oct 22, 2018
Updates to Avelas Biosciences Management Team
Read more -
Aug 02, 2018
Avelas Biosciences Initiates Period 2 of Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Read more -
Jan 04, 2018
Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Read more
